International Society of Liquid Biopsy shared on LinkedIn:
“Join us for the next session of the ISLB Global Molecular Tumor Board Education Series, focusing on Lung Cancer.
This 30-minute interactive virtual session will bring together global perspectives in thoracic oncology and molecular diagnostics.
The program will feature two clinical cases, covering:
- Early-stage lung cancer
- Advanced/metastatic lung cancer
- Molecular testing and interpretation
- Clinical decision-making
- Practical educational takeaways
Date: Monday, August 31, 2026
9:00 – 9:30 AM ET
3:00 – 3:30 PM CET
9:00 – 9:30 PM CST
Faculty and Speakers
Moderators:
Bruna Pellini – Miami Cancer Institute
Remon Jordi – Gustave Roussy
Presenter:
Meimei Zheng
Invited Panelists:
Fabio Tavora, Atocha Romero, Aaron Tan
Registration is free and open to all ISLB members and healthcare professionals.
Register here:
We look forward to seeing you there!”
Enes Erul, Oncology Fellow at Ankara University, shared the update:
“Virtual molecular tumor boards are incredibly valuable for education and for sharing expertise across borders.
The ISLB is committed to playing a central role in advancing these efforts on a global scale to support the equitable and effective implementation of liquid biopsy.”
Read our latest article on lung cancer: RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC
